Shumaila, “Long-Term Safety and Efficacy of Janus kinase (JAK) Inhibitors in the Treatment of Rheumatoid Arthritis: Disease Control in Rheumatoid Arthritis with JAK Inhibitors”, Dev. med. life sci., vol. 1, no. 4, pp. 12–16, Jun. 2024, doi: 10.69750/dmls.01.04.039.